PE20070120A1 - Derivados de prostaglandina - Google Patents

Derivados de prostaglandina

Info

Publication number
PE20070120A1
PE20070120A1 PE2006000747A PE2006000747A PE20070120A1 PE 20070120 A1 PE20070120 A1 PE 20070120A1 PE 2006000747 A PE2006000747 A PE 2006000747A PE 2006000747 A PE2006000747 A PE 2006000747A PE 20070120 A1 PE20070120 A1 PE 20070120A1
Authority
PE
Peru
Prior art keywords
prostaglandin
cyclopentil
nitrooxy
dihydroxy
hydroxy
Prior art date
Application number
PE2006000747A
Other languages
English (en)
Inventor
Francesca Benedini
Wesley Kuan Mung Chong
Michael Ross Niesman
Ennio Ongini
Achim Krauss
Valerio Chiroli
Original Assignee
Pfizer
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Nicox Sa filed Critical Pfizer
Publication of PE20070120A1 publication Critical patent/PE20070120A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA R-X-(B)m-Y-ONO2 DONDE R ES EL RESIDUO DE PROSTAGLANDINA DE FORMULA (II) DONDE --- ES UN ENLACE SENCILLO O UN DOBLE ENLACE; L ES BENCILO, HEXILO, ENTRE OTROS; X ES NR1, DONDE R1 ES H O ALQUILO(C1-C6); m ES 0 O 1; B ES CH-(R1')COO, DONDE R1' ES H O ALQUILO(C1-C10) OPCIONALMENTE SUSTITUIDO CON OH, COOH, CONH2, ENTRE OTROS; Y ES ALQUILENO(C1-C20) OPCIONALMENTE SUSTITUIDO CON HALOGENO, OH, ENTRE OTROS, CICLOALQUILENO(C5-C7), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N-METIL-N-(3-(NITROOXI)PROPIL) AMIDA DEL ACIDO [1R-[1A(Z),2B(R*),3A,5B]]-7-[3,5-DIHIDROXI-2-(3-HIDROXI-5-FENILPENTIL)CICLOPENTIL]-5-HEPTENOICO; 6-(NITROOXI)HEXIL AMIDA DEL ACIDO [1R-[1A(Z),2B(R*),3A,5A]]-7-[3,5-DIHIDROXI-2-(3-HIDROXI-5-FENILPENTIL)CICLOPENTIL]-5-HEPTENOICO, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE GLAUCOMA E HIPERTENSION OCULAR
PE2006000747A 2005-06-29 2006-06-27 Derivados de prostaglandina PE20070120A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69638305P 2005-06-29 2005-06-29

Publications (1)

Publication Number Publication Date
PE20070120A1 true PE20070120A1 (es) 2007-02-09

Family

ID=37309319

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000747A PE20070120A1 (es) 2005-06-29 2006-06-27 Derivados de prostaglandina

Country Status (11)

Country Link
US (1) US7718656B2 (es)
EP (1) EP1899295A2 (es)
JP (1) JP2009501150A (es)
AR (1) AR057414A1 (es)
CA (1) CA2613748A1 (es)
GT (1) GT200600277A (es)
NL (1) NL1032046C2 (es)
PE (1) PE20070120A1 (es)
TW (1) TW200730179A (es)
UY (1) UY29627A1 (es)
WO (1) WO2007000641A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2604562T3 (es) 2007-02-05 2017-03-07 Nicox Science Ireland Compuestos donantes de óxido nítrico
US7960379B2 (en) 2008-03-14 2011-06-14 Allergan, Inc. Therapeutic compounds
AR076731A1 (es) * 2008-05-09 2011-07-06 Pfizer Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas
WO2013126156A1 (en) * 2012-02-22 2013-08-29 Bausch & Lomb Incorporated Nitric oxide donating selective glucocorticoid receptor agonist compounds and ophthalmic compositions
EP2826491A1 (en) 2013-07-15 2015-01-21 Nicox Science Ireland Ophthalmic compositions containing a nitric oxide donor
CA2964364A1 (en) * 2014-10-15 2016-04-21 Novartis Ag Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension
US10047047B2 (en) 2015-03-31 2018-08-14 Nicox S.A. Nitric oxide donating derivatives of latanoprost free acid
WO2016155906A1 (en) * 2015-03-31 2016-10-06 Nicox S.A. Nitric oxide donating derivatives of fluprostenol
EP3088388A1 (en) 2015-04-30 2016-11-02 NicOx S.A. Nitric oxide donating derivatives of prostaglandins
BR112019009330A2 (pt) 2016-11-08 2019-07-30 Bausch & Lomb composto
KR102069205B1 (ko) * 2017-08-09 2020-01-22 연성정밀화학(주) 라타노프로스틴 부노드의 제조 방법 및 그를 위한 중간체

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922293A (en) 1971-12-30 1975-11-25 Upjohn Co Prostaglandin F-type 9-monoacylates
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
WO1990002553A1 (en) * 1988-09-06 1990-03-22 Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
WO1994008585A1 (en) 1992-10-13 1994-04-28 Alcon Laboratories, Inc. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
US5625083A (en) * 1995-06-02 1997-04-29 Bezuglov; Vladimir V. Dinitroglycerol esters of unsaturated fatty acids and prostaglandins
IT1295694B1 (it) 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1292377B1 (it) 1997-06-19 1999-02-08 Nicox Sa Composizioni farmaceutiche a base di prostaglandine
US6417228B1 (en) 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
US7186744B2 (en) 2003-11-13 2007-03-06 Allergan, Inc. Prostamides for the treatment of glaucoma and related diseases
EP1704141B1 (en) * 2004-01-05 2016-02-24 Nicox S.A. Prostaglandin nitrooxyderivatives

Also Published As

Publication number Publication date
US7718656B2 (en) 2010-05-18
TW200730179A (en) 2007-08-16
EP1899295A2 (en) 2008-03-19
US20090062296A1 (en) 2009-03-05
WO2007000641A3 (en) 2007-03-22
NL1032046A1 (nl) 2007-01-02
WO2007000641A2 (en) 2007-01-04
NL1032046C2 (nl) 2007-04-24
UY29627A1 (es) 2007-01-31
JP2009501150A (ja) 2009-01-15
CA2613748A1 (en) 2007-01-04
GT200600277A (es) 2007-02-14
AR057414A1 (es) 2007-12-05
WO2007000641A8 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
PE20070120A1 (es) Derivados de prostaglandina
PE20051052A1 (es) Derivados nitrooxi de prostaglandinas
CY1113138T1 (el) Παραγωγα 10,10-διαλκυλ προστανοϊκου οξεος ως παραγοντες για μειωση ενδο-οφθαλμικης πιεσης
PE20091065A1 (es) Derivados bis-(sulfonilamino) en terapia 066
PE20011371A1 (es) Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5
CY1110969T1 (el) 5-υποκατεστημενα-2-φαινυλαμινο-βενζαμιδια ως αναστολεiς μεκ
TW200718424A (en) Novel compounds of amino sulfonyl derivatives
NO20074390L (no) Forsterket bimatoprost oye-opplosning
PE20050142A1 (es) 2-hidroxi-3-diaminoalcanos de benzamida
HUP0301427A2 (hu) Fotokemoterápiában alkalmazható fotoszenzitizáló, 5-aminolevulinsavészterek azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
EA200500814A1 (ru) Производные пирролопиримидина
PE20060298A1 (es) Derivados de acido carboxilico de bencimidazolona
EA200702498A1 (ru) N-(пиридин-2-ил)сульфонамидные производные
TR200103095T2 (tr) Renin engelleyiciler.
NO20053715L (no) 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk
EA200501061A1 (ru) N-(1-бензил-2-оксо-2-(1-пиперазинил)этил)-1-пиперидинкарбоксамидные производные и родственные соединения в качестве cgrp-антагонистов для лечения головных болей
RU2007132179A (ru) Ингибирующие вич производные 2-(4-цианофениламино)пиримидина
DK1395263T3 (da) 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk
FI102753B1 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten substituoitujen tiatsolyyli- ja pyridinyylijohdannaisten valmistamiseksi
IT1256320B (it) Derivati eterociclici
TW200817378A (en) Compositions and methods for treating or preventing glaucoma or progression thereof
EA200501204A1 (ru) Производные 3-(1-[3-(1,3-бензотиазол-6-ил)пропилкарбамоил]циклоалкил)пропановой кислоты в качестве ингибиторов нейтральной эндопептидазы (nep)
WO2005061492A1 (ja) 含窒素複素環化合物およびそれらを有効成分とする薬剤
PE20030240A1 (es) DERIVADOS DE BENZO [g] QUINOLINA
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций

Legal Events

Date Code Title Description
FC Refusal